CASP1 and Alzheimer disease: Current data suggest IL-1β polymorphisms may associate with AD risk, although caspase-1 polymorphisms do not (Griffin et al., 2000; McGeer and McGeer, 2001; Shaftel et al., 2008; Vazquez-Higuera et al., 2010).